←Back to Expert Scholars
Translational Medicine / 转化医学Plasma NGS in Lung Cancer
Geoffrey Oxnard
MD
🏢Dana-Farber Cancer Institute / Foundation Medicine🌐USA
Medical Director, Thoracic Oncology
68
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Geoffrey Oxnard pioneered clinical use of plasma EGFR T790M testing in NSCLC. His work established ctDNA as a practical alternative to tissue biopsy for resistance detection. He has led development of comprehensive liquid biopsy platforms for thoracic oncology.
Share:
🧪Research Fields 研究领域
Liquid biopsy
EGFR T790M
ctDNA
Plasma NGS
Precision oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Geoffrey Oxnard 的研究动态
Follow Geoffrey Oxnard's research updates
留下邮箱，当我们发布与 Geoffrey Oxnard（Dana-Farber Cancer Institute / Foundation Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment